Axcelis Technologies Inc (ACLS)

[TucsonPhil]

Adjusting to 175, with possibly a little overshoot. A quick 8% profit turn from last week, if you are trading, but this looks like a long-term hold stock. Just my opinion.

[TucsonPhil]

Consolidating for a little bump to 180.

[Monksdream]

ACLS new 52 week high

[Monksdream]

Axcelis Technologies Inc NASDAQ: ACLS

GoSymbol lookup
Information Technology : Semiconductors & Semiconductor Equipment | Small Cap GrowthCompany profile
Axcelis Technologies, Inc. designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company offers a complete line of high energy, high current and medium current implanters for all application requirements. In addition to equipment, the Company provides extensive aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. Its Purion flagship systems are all based on a common platform, which enables a combination of implant purity, precision and productivity. Combining a single wafer end station, with advanced spot beam architectures (that ensures all points across the wafer see the same beam condition at the same beam angle), Purion products enable process control to optimize device performance and yield, at high productivity. The Company sells its products to semiconductor chip manufacturers around the world.

[peterquinnvet]

The next semiconductor growth stock investors should buy now and hold is Axcelis Technologies ( ACLS 7.66% ). In a similar fashion to Cohu, Axcelis provides crucial equipment to semiconductor producers. Its ion implanters are essential to the fabrication process for chipmakers, and investors are taking notice of the company's value to the industry.

Since hitting its pandemic-low price in March 2020, Axcelis stock has soared by over 350%, making it one of the best performers in the entire sector. It has backed this up with a solid operational performance, nearly doubling its earnings per share to $2.88 in 2021, thanks to soaring demand for equipment in its Purion Power Series line.

That line of ion implantation equipment is used to fabricate chips for a wide range of segments including automotive, mobile, and even artificial intelligence. The company has released a series of announcements since September 2021 informing investors of large shipments of its Purion Power Series products to semiconductor producers across the globe.

Axcelis is so confident in its position that it just announced a share buyback program, with the goal to return $100 million to shareholders -- adding yet another reason to buy its stock.

https://www.fool.com/investing/2022/03/08/5-semiconductor-growth-stocks-to-buy-now-and-hold/

[whytestocks]

News: $ACLS UPDATE: Axcelis Announces Timing And Availability Of Fourth Quarter And Full Year 2018 Results And Conference Call

BEVERLY, Mass. , Jan. 24, 2019 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) will release financial results for the fourth quarter and full year 2018 on Wednesday, February 6, 2019 at 5:00 p.m. Eastern Time (ET).  The Company will host a...

Got this from https://marketwirenews.com/news-releases/update-axcelis-announces-timing-and-availability-of-fourth-quarter-and-full-year-2018-results-and-conference-call-7549462.html

[bullitt23]

It looks like a good run here

[The Other Guy]

Axcelis Receives Order For 'Purion XE' From Power Device Chipmaker In European Region

Source: PR Newswire (US)
BEVERLY, Mass., Sept. 8, 2016 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced that it has received an order for the Purion XE™ high energy implanter from a leading semiconductor manufacturer in the European region. The system will be used to support R&D activities as well as a capacity expansion for the production of power devices for automotive, IoT and image sensor markets. The system is scheduled to ship in the third quarter.

Axcelis Technologies, Inc.


Executive Vice President, Customer Operations John Aldeborgh, said, "We are very pleased about this new opportunity for the Purion XE high energy implanter, and look forward to supporting this customer's ramp in manufacturing capacity and development of next generation device technology. The system's wide energy range, high beam currents and low levels of contamination provide industry leading productivity, exceptional manufacturing flexibility and device yields, making it ideal for high volume production and R&D."

[The Other Guy]

Hopefully we are seeing the post-RS consolidation by Institutional investors coming to a close here and the stock price can work upwards.

Sales in Europe should be showing some signs.

[1center]

$ACLS..Axcelis Technologies..The Company reported second quarter revenue of $64.5 million, compared to $67.5 million for the first quarter of 2016. Operating profit for the quarter was $4.6 million, compared to $2.5 million for the first quarter. Net income for the quarter was $2.9 million, or $0.10 per diluted share. This compares to net income for the first quarter of 2016 of $1.9 million, or $0.06 per diluted share. Cash, cash equivalents and restricted cash were $67.8 million on June 30, 2016, compared to $74.4 million on March 31, 2016.

"During the second quarter, we made significant progress towards expanding our customer base through new penetrations and capacity buys, as well as offering new product line extensions to address emerging market needs," said President and CEO Mary Puma. "These actions position us well for a strong build cycle in 2017, which will drive continued market share gains."

Business Outlook

For the third quarter ending September 30, 2016, Axcelis expects revenues of $65-$70 million. Gross margin in the third quarter is expected to be in the mid 30% range. Third quarter operating profit is forecasted to be approximately $2.5-3.5 million with $0.03-0.06 earnings per diluted share.

[1center]

$ACLS..10.93 +0.17 (+1.58%). Actually a good day following the 4/1 RS..http://finance.yahoo.com/q/ks?s=ACLS+Key+Statistics

[1center]

$ACLS Axcelis..at the B.Riley & Company Investor Conference...
#technology
http://www.wsw.com/webcast/brileyco17/acls/

[venturecapp]

Axcelis Technologies To Deliver Purion EXE In Asia http://marketexclusive.com/axcelis-technologies-inc-nasdaqacls-deliver-purion-exe-asia/7239/?icd1

[1center]

$ACLS..Many of our customers who need to ramp capacity...
RECENT INSIGHTS
5 Essential Upgrades for 200mm That You Should Consider Now


It has been a strong year for the 200mm implant market as growth in mobile applications and the Internet of Things drive demand for more capable and cost effective devices. Many fabs are at capacity, and in search of upgrades that bring added productivity and performance. The solutions below deliver customer inspired upgrades for long term value. Our goal is to increase implanter productivity, precision and capability with the aim of reduced cost of ownership. Below are 5 of the most successful upgrades that are proven to satisfy customer productivity and cost of ownership needs.

1. GSD High Performance End Station
Quickly Adds Capacity and Reduces CoO

Many of our customers who need to ramp capacity and are four-walled constrained have requested a solution that can increase capacity as well as improve their process. The GSD High Performance End Station (HPES) upgrade was developed specifically to address these needs. Customers using this upgrade in production report up to a 17% increase in wafers implanted per day, and up to a 53% reduction in defectivity. The HPES is a hardware and software integrated productivity upgrade. It combines advanced wafer handling hardware with low g-force mechanics, to improve the ratio between implant and non-implant time by eliminating up to 50% of in-vacuum wafer handling time. This upgrade is available on nearly all GSD models and is the fastest and most cost effective way to quickly add capacity.

The new in-vac wafer holder and cam-driven transfer arm assemblies enable up to a 50% improvement in disk load and unload time with measurably better defect performance. The cam-driven transfer arm allows for precise wafer placement, repeatable end station set up and virtually eliminates related wafer drops. The HPES reduces your cost of consumables, labor & energy on a per wafer basis. All together, the upgrade effectively increases your implant bay productivity with no additional clean room space required.

Customer data shows an average of 10.7% increase in productivity and up to a 53% reduction in defectivity.

http://www.axcelis.com/knowledge-center/recent-insights

[1center]

$ACLS..growing demand in the mobile and #IoT markets...

Axcelis Announces Shipment Of First 'Purion EXE' To Leading Foundry In Asia Pacific Region

Axcelis Announces Shipment Of First 'Purion EXE' To Leading Foundry In Asia Pacific Region
Print
Alert
Axcelis Technologies, Inc. (MM) (NASDAQ:ACLS)
Intraday Stock Chart
Today : Thursday 26 May 2016

Click Here for more Axcelis Technologies, Inc. (MM) Charts.
BEVERLY, Mass., May 25, 2016 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of innovative, high-productivity solutions for the semiconductor industry, announced today that it has received its first order for the Purion EXE™, an extended energy range option for its industry leading Purion XE™ high energy implanter. The 200mm Purion EXE will be used to support the production of specialty devices to meet the growing demand in the mobile and IoT markets. The system is scheduled to ship in the second quarter.
Aldeborgh, executive vice president, customer operations, commented, "We're excited to be able to offer customers a new system with the ability to perform ultra-high energy implants, with extremely precise and deep doping profiles, on the industry leading Purion XE platform. The applications for these implants are expanding in the specialty device markets, providing strong opportunities for the Purion XE platform."

Bill Bintz, executive vice president, engineering and marketing, commented, "The Purion platform's common architecture, in conjunction with its LINAC technology, has allowed Axcelis to rapidly expand the capabilities of our high energy product line. As a result, we are able to meet the emerging needs of device manufacturers, while simultaneously delivering exceptional reliability, manufacturing flexibility and capital efficiency. The product line is available in both 200mm and 300mm configurations."

About Axcelis:

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 35 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

http://ih.advfn.com/p.php?pid=nmona&article=71571950&symbol=ACLS

[1center]

$ACLS Axcelis Announces Financial Results For First Quarter 2016
Axcelis Announces Financial Results For First Quarter 2016

Company Reports Solid Quarterly Results and Significant Market Share Gains Driven by Purion Platform

PR Newswire

BEVERLY, Mass., May 2, 2016

BEVERLY, Mass., May 2, 2016 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the first quarter ended March 31, 2016.

Highlights for the quarter include:

-- Total revenues of $67.5 million were above guidance:

-- System revenues of $37 million.

-- Operating profit of $2.5 million.

-- Net income of $1.9 million or $0.02 per share.

-- Increased Axcelis market share:

-- Increased total market share to 18.3% in 2015 up from 12.4% in

2014.

-- Doubled high current market share from 6% in 2014 to 12.4% in

2015, driven by the Purion H, the fastest growing new product in

Axcelis history.

The Company reported first quarter revenue of $67.5 million, compared to $70.5 million for the fourth quarter of 2015. Operating profit for the quarter was $2.5 million, compared to $2.4 million for the fourth quarter. Net income for the quarter was $1.9 million, or $0.02 per share. This compares to net income for the fourth quarter of 2015 of $0.8 million, or $0.01 per share. Cash, cash equivalents and restricted cash were $74.4 million at March 31, 2016, compared to $85.8 million on December 31, 2015.

"We're pleased with our execution against strategic initiatives in the first quarter that will continue to drive Purion platform market share gains in 2016," said President and CEO Mary Puma. "We remain focused on broadening our customer base, driving gross margin improvements and delivering stronger financial performance in the second half of 2016."

Business Outlook

For the second quarter ending June 30, 2016, Axcelis expects similar financial results as in the first quarter, with revenues to be in the mid $60 million range. Gross margin in the second quarter is expected to be in the mid 30% range. Second quarter operating profit is forecasted to be approximately $1-2 million with breakeven to $0.01 earnings per share.

First Quarter 2016 Conference Call

The Company will host a conference call today, Monday, May 2, 2016 at 5:00 pm ET, to discuss results for the first quarter 2016. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by dialing 866.588.8911 (707.294.1561 outside North America). Participants calling into the conference call will be requested to provide the company name, Axcelis Technologies, and pass code: 82784852. Webcast replays will be available for 30 days following the call.

[1center]

$ACLS.. Board to implement a one-for-four reverse stock split.

https://biz.yahoo.com/e/160411/acls8-k.html

[willlbone]

Broke under $2.00

[twksk8]

Sticking around at 2.75? Or waiting to get back to 3?

[1center]

$ACLS Q4 guide lower..Strong third quarter results demonstrate our progress in gaining market share and improving profitability,” said President and CEO Mary Puma. “The rapid adoption of the Purion platform across multiple customers has strengthened Axcelis, allowing us to address the upcoming industry slowdown from a much stronger position. As a result, Axcelis will enter the next upturn with higher market share, a larger and growing customer base, new product capabilities and higher earnings potential.”

So we watch and wait. Still holding some @2.75

[twksk8]

Why the immediate drop after the report today? Seems good to me.. Did it fall short in some way?

[1center]

Axcelis Technologies $ACLS Q3 EPS of $0.05 beats by $0.01.Revenue of $79.31M (+105.8% Y/Y) beats by $1.19M.Press Release

[twksk8]

Whoops. Where'd the floor go?

[twksk8]

Everything took a dip today. We're good for a while I believe.

[heromrk18]

looks like it took quite the dip today.. can we expect a rally or is this the end?

[1center]

$ACLS Another 52week high...
http://investor.axcelis.com/mobile.view?c=121859&v=203&d=1&id=2075597

[1center]

I'm liking the strength $ACLS #tech
http://ih.advfn.com/stock-market/NASDAQ/axcelis-technologies-inc-mm-ACLS/stock-price

[1center]

Haven't yet nibbled but may grab a few more..Watching $ACLS
#tech

[twksk8]

Holding for sure! It was tough to hold through the pre-ER dip, but we're looking good for a gentle ride up now!

[1center]

Axcelis delivers 10.8% gain following Q2 beat, strong Q3 guidance no
SA $ACLS
http://seekingalpha.com/news/2700465-axcelis-delivers-10_8-percent-gain-following-q2-beat-strong-q3-guidance?uprof=45

Holding all, at this point,

[twksk8]

Looking pretty good today, hopeful we become stable and see continued gains toward $4.00 this quarter.

[1center]

ACLS Q2 CC Aug 4 2015..http://edge.media-server.com/m/p/iqsdd35y/lan/en

PPS @2.87

[twksk8]

Time to ride!

[twksk8]

Yeah maybe so! Things seem a little stalled right now awaiting earnings news... Just surprised the pr lately hasn't done more. With a high target and good news? Seems strange!

[1center]

I think we do well quietly....
$ACLS
Accumulating, Company doing great with a small
share structured 113m OS

[twksk8]

It sure is quiet here for all the potential I'm seeing. It seems like big news is treated like small news... Is there something obvious other than a little insider selling that I'm unaware of with ACLS???

[1center]

$ACLS @2.98..the fourth chipmaker to select the Purion H. The Purion H will be used to develop and manufacture advanced memory devices. The system is scheduled to ship in the third quarter.

John Aldeborgh, executive vice president, customer operations, commented, "This is a significant win for Axcelis. This selection is further evidence of the competitiveness of the Purion H. The Purion platform was specifically designed to address the industry's most challenging technical and economic requirements for advanced planar and emerging 3D devices."

http://ih.advfn.com/p.php?pid=nmona&article=67678763

[1center]

Recently started a position $ACLS
200@ 3.04
http://finance.yahoo.com/q?s=ACLS

[The Other Guy]

Beat estimates by 2c and we only gain 18c. With the new customer wins ACLS will eventually break out of the $2's.

[Bocephus]

Huge numbers on the 10Q. This looks like one to own.

[rusty8350]

Picked up some ACLS today. Looking good here.

[interloper]

News for 'ACLS' - (*DJ Axcelis Technologies Files $75 Million Mixed-Securities Shelf)

Under a mixed securities shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale. They may sell common and preferred stock as well as debt securities

[The Other Guy]

Charts for ACLS are looking highly positive for a continued push upwards. I like the wins the company is getting. And I look forward to seeing some positive earnings shortly. This is not going to spike, however, I can see it continuing an upward curve to $3 in upcoming weeks.

[AtlasSnuggled]

yasuh yasuh! Guess that latest load of 210s are ripening sooner than expected.
I suppose the chart meant to BUY those stone drops ... but having stones always beats having a LOLly pop. Sure is nice to get some income for selling product , instead of selling off more of the company ! So many good choices out there, just gotta avoid the FRAUDS.

[AtlasSnuggled]

rofl or pratfall on an oily floor.
just sold a bunch of 2.08-2.10 that hadn't even settled yet.
hope this falls like a stone again, these stones are diamonds

[AtlasSnuggled]

yeah I took a little taste before the very positive CC.
Of course I made a total pig of myself across that triple bottom.
Starting to see how this thing works eh?
Wonder how its going elsewhere ROTMFFLMAO.

[AtlasSnuggled]

Purchase2013-08-13 ACLS THOMPSON H BRIAN (Director) 20,000
$1.952 $39,050 104,185

[AtlasSnuggled]

Purchase 2013-08-13
09:58 am AXCELIS TECHNOLOGIES INC ACLS HARDIS STEPHEN R
(Director) 24,148 $1.85 $44,674 672,068

Purchase 2013-08-12
09:43 am AXCELIS TECHNOLOGIES INC ACLS FLETCHER R JOHN
(Director) 10,000 $1.84 $18,400 94,185

Purchase 2013-08-08
11:00 am AXCELIS TECHNOLOGIES INC ACLS JENNINGS WILLIAM C
(Director) 10,000 $1.857 $18,571 92,185

Pickinup on how this works now ? very nice run peaks before call, call decently positive, recent TRIPLE run off sold a bit, insiders jump to market-buy up slack, trajectory resumes. All those $1.8x's are looking pretty timely indeed

[Rawnoc]

ROFL.....this info marked the very top for ACLS and has been dropping like a stone since.

[AtlasSnuggled]

We expect to see improvement in market conditions in Q2 and are currently projecting Q2 revenues to be in the $45 million to $50 million range. We expect that the sequential increase will come primarily from system sales. Q2 gross margins are projected to be in the mid-30% range. Q2 operating expenses should be essentially unchanged from Q1, excluding an $800,000 milestone payment that we received from Lam in April. As a result of these factors, we expect to report a Q2 operating loss of approximately $3 million to $6 million and an earnings loss of approximately $0.03 to $0.05 per share. We are projecting that our cash balance will decline in Q2 and that we will end the quarter with a cash balance in the mid-$30 million range. This reduction will be driven primarily by our projected operating losses, restructuring payments associated with the previously announced actions and continued R&D investments in our Purion platform.